Earlier this month at #COOC2026#Shanghai, we showcased #MetaRx—Akeso’s platform for personalised myopia management. Great conversations, valuable insights, and exciting steps for better vision care. #EyeHealth
Strong interest and meaningful conversations at #COOC2026 as visitors explored Akeso’s #MetaRx and vision care innovations. Grateful for the engagement from clinicians, researchers, and partners in Shanghai!
Proud to share a closer look at Akeso’s presence at #COOC2026 in Shanghai—from #MetaRx and #Airlens to #Eyelign, it was great to join the conversation on the future of vision care.
Read more: https://t.co/5iI5cVTM3e
Photolithography vs laser ablation: the difference in lens technology defines comfort, clarity, and durability. Discover how Akeso MetaRx is setting a new standard in vision care: https://t.co/74T8mdXcnT
#VisionCare#MedTech
Akeso welcomed government leaders to its Danyang HQ, showcasing AI-driven vision systems and precision photolithography advancing myopia care and the future of eye health. #MedTech#VisionTech
Akeso presented LightGazeNet, a lightweight GNN architecture for gaze estimation, at WACV 2026. Our team shared research on efficient, multimodal gaze prediction for next-gen intelligent vision systems.
Read more about the research paper here: https://t.co/FJIVajVogb
Evosight Desk™ and Evosight Flip™ debuted at #SIOF2026, showcasing Akeso’s far-sight optical solutions designed to promote healthier viewing habits and support myopia management in modern learning environments.
FlexFocus is one of AKESO’s ongoing research projects exploring adaptive optics in #visiontechnology. At #SIOF2026, we shared an early look at these lenses that dynamically adjust optical power to support near-to-distance tasks and future #ophthalmic systems.
#OpticsIndustry#XR
At SIOF 2026, Akeso showcased MetaRx Airlens, exploring how nano-optic lens design can deliver clear vision in ultra-thin form factors. Global visitors discussed its potential for lighter eyewear and future smart vision systems. #SIOF2026#OpticsIndustry
Akeso introduces StellarGuard™, a clinically backed preventive myopia solution for children with advanced defocus optics and photochromic protection.
#MyopiaControl#VisionTech
Read more: https://t.co/3b7pigH466
Akeso CEO Dr. Cai Xiaogu receives the Emerging Talent Award for pioneering MetaRx™ lithography in personalized vision care and myopia management.
Read more: https://t.co/8w3A7jplnH
#VisionTech#OpticalEngineering#MedTech
Great discussions at #SIOF2026 as @ZEISS_Group research and product teams visited the Akeso booth to explore MetaRx™ lithographic optics and next-gen imaging platforms, reflecting growing global interest in nano-optics innovation.
#OpticsIndustry#Shanghai#OpticalTechnology
Akeso showcased MetaRx™ lithography in Chengdu, applying semiconductor-grade nanometer precision to personalized myopia management. With OptiDynamic™ AI and StellarGuard™ lenses, precision eyewear enters a new era.
Read more: https://t.co/GlWf0hH8ya
As we welcome the Year of the Horse, Akeso Eyecare wishes you positive energy, confidence, & success in 2026. May it bring bold ideas, steady wins, and new milestones. 🎉
Thank you for being part of our journey in building smarter, more precise vision care! 🐎✨
Dr. Cai Xiaogu, CEO of Akeso, named “Jingxian Talent” Young Top Talent honouree, recognising innovation in optics, AI myopia control & digital vision health. #VisionTech
https://t.co/OlYNgRQYgt
Akeso wins the 2025 Beijing Maker Award 🏆 for its MetaRx™ AI lithography myopia solution, setting a new standard in precision optics and personalized vision care. #VisionInnovation#MyopiaManagement#OpticalTech
Read more: https://t.co/K8c1k6njTp
Akeso debuted Stellar Guard™ at CIOF 2025, the world’s first photochromic defocus lens for myopia prevention, combining MetaRx™ lithography, advanced materials, and intelligent manufacturing: https://t.co/cE2CaS63zB
On Jan 21, 2026, Akeso launched a 12-month double-blind RCT with Shanghai Eye Disease Prevention and Treatment Center to validate MetaRx™ lens safety, comfort, and effectiveness for precision myopia control.
Read more here: https://t.co/2687qFygR4